JPMORGAN CHASE & CO - ENDOCYTE INC ownership

ENDOCYTE INC's ticker is ECYT and the CUSIP is 29269A102. A total of 73 filers reported holding ENDOCYTE INC in Q4 2017. The put-call ratio across all filers is 1.41 and the average weighting 0.0%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of ENDOCYTE INC
ValueSharesWeighting
Q3 2018$2,537,000
+1286.3%
142,854
+974.3%
0.00%
Q2 2018$183,000
+150.7%
13,298
-75.3%
0.00%
Q3 2017$73,000
-79.9%
53,778
-77.8%
0.00%
Q2 2017$364,000
-76.8%
242,466
-60.3%
0.00%
Q1 2017$1,570,000
-22.0%
611,043
-22.6%
0.00%
Q4 2016$2,014,000
-9.7%
789,735
+9.4%
0.00%
-100.0%
Q3 2016$2,230,000
-11.2%
721,675
-7.8%
0.00%0.0%
Q2 2016$2,512,000
+31300.0%
782,485
+30170.2%
0.00%
Q1 2016$8,000
-97.4%
2,585
-88.9%
0.00%
Q3 2013$310,000
-29.9%
23,245
-30.9%
0.00%
Q2 2013$442,00033,6450.00%
Other shareholders
ENDOCYTE INC shareholders Q4 2017
NameSharesValueWeighting ↓
Corbenic Partners LLC 32,639$83,0000.09%
Anson Funds Management LP 108,426$276,0000.09%
Leisure Capital Management 30,038$77,0000.07%
HIGHLAND CAPITAL MANAGEMENT LP 461,561$1,177,0000.06%
Teza Capital Management LLC 14,542$37,0000.05%
PINNACLE ASSOCIATES LTD 821,543$2,095,0000.04%
Cribstone Capital Management, LLC 28,141$63,0000.04%
RMB Capital Management, LLC 243,385$621,0000.03%
Acrospire Investment Management LLC 26,061$66,0000.03%
TWO SIGMA SECURITIES, LLC 26,758$68,0000.02%
View complete list of ENDOCYTE INC shareholders